Litcius/Paper detail

A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma

Simon Chowdhury, J. Infante, Robert D. Hawkins, Martin H. Voss, Rodolfo F. Perini, Tobias Arkenau, Mark Voskoboynik, Paola Aimone, Naëije Isabelle, Albert Reising, David F. McDermott

2021Clinical Genitourinary Cancer38 citationsDOIOpen Access PDF

Topics & Concepts

PazopanibMedicinePembrolizumabRenal cell carcinomaOncologyInternal medicineKidney cancerCancerImmunotherapySunitinibRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis
A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma | Litcius